Literature DB >> 29161659

Lipopolysaccharide (LPS)-mediated priming of toll-like receptor 4 enhances oxidant-induced prostaglandin E2 biosynthesis in primary murine macrophages.

Yan Zhang1, Orisa J Igwe2.   

Abstract

Agonists and pseudo-agonists for toll-like receptor 4 (TLR4) are common in our environment. Thus, human exposure to these agents may result in "priming or sensitization" of TLR4. A body of evidence suggests that LPS-mediated sensitization of TLR4 can increase the magnitude of responses to exogenous agents in multiple tissues. We have previously shown that reactive oxygen and nitrogen species (RONS) stimulate TLR4. There is no evidence that LPS-primed TLR4 can influence the magnitude of responses to oxidants from either endogenous or exogenous sources. In the present study, we directly tested the hypothesis that LPS-primed TLR4 will sensitize primary murine peritoneal macrophages (pM) to oxidant-mediated prostaglandin E2 (PGE2) production. We used potassium peroxychromate (PPC) and potassium peroxynitrite (PPN) as direct in vitro sources of exogenous RONS. Our results showed that a direct treatment with PPC or PPN alone as sources of exogenous oxidants had a limited effect on PGE2 biosynthesis. In contrast, pM sensitized by prior incubation with LPS-EK, a TLR4-specific agonist, followed by oxidant stimulation exhibited increased transcriptional and translational expression of cyclooxygenase-2 (COX-2) with enhanced PGE2 biosynthesis/production only in pM derived from TLR4-WT mice but not in TLR4-KO mice. Thus, we have shown a critical role for LPS-primed TLR4 in oxidant-induced inflammatory phenotypes that have the potential to initiate, propagate and maintain many human diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyclooxygenases; Oxidative stress; Phospholipase A2; Primary murine macrophages; Toll-like receptor 4

Mesh:

Substances:

Year:  2017        PMID: 29161659      PMCID: PMC5732025          DOI: 10.1016/j.intimp.2017.11.017

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  61 in total

1.  Prostaglandin E2: igniting the fire.

Authors:  Carlo Chizzolini; Nicolò C Brembilla
Journal:  Immunol Cell Biol       Date:  2009-08-11       Impact factor: 5.126

2.  Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.

Authors:  Lihong Chen; Guangrui Yang; James Monslow; Leslie Todd; David P Cormode; Jun Tang; Gregory R Grant; Jonathan H DeLong; Soon Yew Tang; John A Lawson; Ellen Pure; Garret A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

Review 3.  Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders.

Authors:  Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2010-12-28       Impact factor: 7.217

4.  Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages.

Authors:  F D'Acquisto; T Iuvone; L Rombolà; L Sautebin; M Di Rosa; R Carnuccio
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

5.  Pathogen associated molecular pattern motifs from Gram-positive and Gram-negative bacteria induce different inflammatory mediator profiles in equine blood.

Authors:  A E Declue; P J Johnson; J L Day; J R Amorim; A R Honaker
Journal:  Vet J       Date:  2011-10-04       Impact factor: 2.688

6.  Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2.

Authors:  Antonio Carlos Pinheiro de Oliveira; Eduardo Candelario-Jalil; Harsharan S Bhatia; Klaus Lieb; Michael Hüll; Bernd L Fiebich
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Evidence that opioids may have toll-like receptor 4 and MD-2 effects.

Authors:  Mark R Hutchinson; Yingning Zhang; Mitesh Shridhar; John H Evans; Madison M Buchanan; Tina X Zhao; Peter F Slivka; Benjamen D Coats; Niloofar Rezvani; Julie Wieseler; Travis S Hughes; Kyle E Landgraf; Stefanie Chan; Stephanie Fong; Simon Phipps; Joseph J Falke; Leslie A Leinwand; Steven F Maier; Hang Yin; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2009-08-11       Impact factor: 7.217

9.  N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice.

Authors:  Xin Jin; Lin Wang; He-Shui Wu; Lei Zhang; Chun-You Wang; Yuan Tian; Jing-Hui Zhang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-06

10.  Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta.

Authors:  C Burdon; C Mann; T Cindrova-Davies; A C Ferguson-Smith; G J Burton
Journal:  Placenta       Date:  2007-01-12       Impact factor: 3.481

View more
  3 in total

1.  Involvement of TLR4 signaling regulated-COX2/PGE2 axis in liver fibrosis induced by Schistosoma japonicum infection.

Authors:  Lan Chen; Xiaofang Ji; Manni Wang; Xiaoyan Liao; Cuiying Liang; Juanjuan Tang; Zhencheng Wen; Ferrandon Dominique; Zi Li
Journal:  Parasit Vectors       Date:  2021-05-25       Impact factor: 3.876

2.  DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer.

Authors:  Yajie Wang; Hua Sun; Zhiyan Xiao; Gang Zhang; Dan Zhang; Xiuqi Bao; Fangfang Li; Shaoyu Wu; Yuanchao Gao; Ning Wei
Journal:  Cell Commun Signal       Date:  2018-09-03       Impact factor: 5.712

3.  The Protective Role of Feruloylserotonin in LPS-Induced HaCaT Cells.

Authors:  Yuzhu He; Byung-Gook Kim; Hye-Eun Kim; Qiaochu Sun; Shuhan Shi; Guowu Ma; Young Kim; Ok-Su Kim; Ok-Joon Kim
Journal:  Molecules       Date:  2019-08-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.